Month: May 2021

Half of patients with vitiligo achieved 90% improvement in facial repigmentation and more than a fourth had 75% improvement in total body repigmentation after long-term treatment with topical ruxolitinib (Jakafi), a randomized controlled study showed. Measurable improvement occurred within 24 weeks and progressively increased during follow-up to 52 and 104 weeks. At the 104-week assessment,
0 Comments